Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FGX
Faircourt Gold Income
C$2.60
+3.6%
C$2.60
C$2.32
C$3.58
C$7.21MN/A5,795 shs2,500 shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$444.56
+0.2%
$406.72
$289.36
$447.42
$144.27B1.42.35 million shs496,626 shs
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$10.00
-1.1%
$10.64
$6.70
$11.49
$2.26B0.811.21 million shs182,190 shs
Pharmerica Co. stock logo
PMC
Pharmerica
$0.00
$22.00
$29.50
N/AN/A283,015 shsN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$290.00
C$293.43
C$280.00
C$327.51
C$716.30M0.81280 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FGX
Faircourt Gold Income
0.00%0.00%0.00%0.00%0.00%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
+0.04%+3.99%+8.74%+14.76%+35.90%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
+0.45%-7.04%-8.64%+3.33%+20.47%
Pharmerica Co. stock logo
PMC
Pharmerica
0.00%0.00%0.00%0.00%0.00%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
0.00%0.00%+1.75%-9.02%-3.33%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FGX
Faircourt Gold Income
N/AN/AN/AN/AN/AN/AN/AN/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.6732 of 5 stars
2.44.02.53.02.52.52.5
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
2.0908 of 5 stars
3.53.00.00.01.92.50.0
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FGX
Faircourt Gold Income
N/AN/AN/AN/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.76
Moderate Buy$440.57-0.90% Downside
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
3.00
Buy$14.0040.00% Upside
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/A

Current Analyst Ratings

Latest GS, SEC, FGX, PMC, and MIR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$450.00 ➝ $504.00
4/30/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$479.00 ➝ $517.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$460.00 ➝ $470.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$349.00 ➝ $360.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$410.00 ➝ $425.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$435.00 ➝ $440.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$390.00 ➝ $405.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$424.00 ➝ $433.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$446.00 ➝ $479.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$450.00 ➝ $478.00
4/8/2024
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
(Data available from 5/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FGX
Faircourt Gold Income
C$1.67M4.33C$4.10 per share0.63C$3.59 per share0.72
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$108.42B1.33$41.59 per share10.69$324.13 per share1.37
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$800.90M2.82$0.95 per share10.48$6.86 per share1.46
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$612.76M1.17C$1,504.93 per share0.19C$634.25 per share0.46

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FGX
Faircourt Gold Income
N/AC$0.2112.56N/AN/AN/AN/AN/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.52B$25.6117.3611.351.388.17%8.65%0.58%7/17/2024 (Estimated)
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
-$96.90M-$0.41N/AN/A-9.87%3.44%1.98%8/7/2024 (Estimated)
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$151.74M-C$84.10N/AN/A24.76%10.04%6.62%5/14/2024 (Estimated)

Latest GS, SEC, FGX, PMC, and MIR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2024Q1 2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.54$11.58+$3.04$11.58$12.94 billion$14.21 billion    
3/28/2024Q4 2023
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AC$34.61+C$34.61C$34.61N/AC$166.73 million
2/13/2024Q4 2023
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/A$0.12+$0.12$0.32N/A$230.40 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FGX
Faircourt Gold Income
C$0.2911.08%N/A139.13%N/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$11.002.47%+28.06%42.95%3 Years
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/AN/AN/AN/AN/A
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/A

Latest GS, SEC, FGX, PMC, and MIR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Quarterly$2.752.77%5/30/20245/30/20246/27/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FGX
Faircourt Gold Income
11.86
7.88
7.88
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
1.98
1.12
0.76
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
0.45
2.19
1.57
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
56.89
1.35
1.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
FGX
Faircourt Gold Income
N/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
78.51%
Pharmerica Co. stock logo
PMC
Pharmerica
89.97%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
FGX
Faircourt Gold Income
N/A2.77 millionN/ANot Optionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
45,300324.53 million322.68 millionOptionable
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
3,000226.06 million221.09 millionOptionable
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/ANot Optionable
Senvest Capital Inc. stock logo
SEC
Senvest Capital
322.47 millionN/ANot Optionable

GS, SEC, FGX, PMC, and MIR Headlines

SourceHeadline
Robinhood Crypto Warned of Coming SEC ActionRobinhood Crypto Warned of Coming SEC Action
inc.com - May 8 at 3:37 AM
Column: Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SECColumn: Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC
reuters.com - May 7 at 5:35 PM
The SEC Is Playing Target Practice With Crypto BusinessesThe SEC Is Playing Target Practice With Crypto Businesses
inc.com - May 7 at 12:34 PM
Closing Bell: Senvest Capital up on Monday (SEC)Closing Bell: Senvest Capital up on Monday (SEC)
theglobeandmail.com - May 7 at 2:34 AM
Hedge Start: When Is SEC Registration Necessary?Hedge Start: When Is SEC Registration Necessary?
natlawreview.com - May 6 at 9:33 PM
SEC, Stakeholders to Brainstorm on Critical Capital Market IssuesSEC, Stakeholders to Brainstorm on Critical Capital Market Issues
thisdaylive.com - May 6 at 9:55 AM
SVB agrees to sell venture capital arm for $340 millionSVB agrees to sell venture capital arm for $340 million
msn.com - May 3 at 9:02 PM
Global Regulatory Brief: Trading and markets, May editionGlobal Regulatory Brief: Trading and markets, May edition
bloomberg.com - May 3 at 9:02 PM
SVB Financial to sell VC business SVB CapitalSVB Financial to sell VC business SVB Capital
msn.com - May 3 at 2:07 AM
Senvest Capital (TSE:SEC) Trading 1.8% Higher Senvest Capital (TSE:SEC) Trading 1.8% Higher
marketbeat.com - April 30 at 12:22 AM
Cornerstone investment regulations issued by SECCornerstone investment regulations issued by SEC
msn.com - April 26 at 12:57 PM
SEC sued over Ethereum, crypto firm asks court to state token is not a securitySEC sued over Ethereum, crypto firm asks court to state token is not a security
msn.com - April 26 at 7:57 AM
SEC Unveils Groundbreaking Report Revealing $26 Trillion in Registered Funds to Foster TransparencySEC Unveils Groundbreaking Report Revealing $26 Trillion in Registered Funds to Foster Transparency
hoodline.com - April 26 at 7:57 AM
Regulators Impose Extraordinary Fine Amounts in Recent Off-Channel Communications Enforcement ActionsRegulators Impose Extraordinary Fine Amounts in Recent Off-Channel Communications Enforcement Actions
jdsupra.com - April 24 at 8:49 PM
SEC Settles Charges with Investment Adviser for Off-Channel Communications Recordkeeping FailuresSEC Settles Charges with Investment Adviser for Off-Channel Communications Recordkeeping Failures
jdsupra.com - April 24 at 8:49 PM
Fund offering ‘venture capital’ exposure sends investors on meme-like rideFund offering ‘venture capital’ exposure sends investors on meme-like ride
kfgo.com - April 24 at 12:09 AM
Senvest Management Enforcement Action – Electronic CommunicationsSenvest Management Enforcement Action – Electronic Communications
jdsupra.com - April 15 at 11:12 PM
SATRIX Collective Investment Scheme Expands Portfolio with New Securities ListingSATRIX Collective Investment Scheme Expands Portfolio with New Securities Listing
msn.com - April 12 at 10:22 AM
SEC to sue Uniswap DEX amid DeFi regulatory crackdownSEC to sue Uniswap DEX amid DeFi regulatory crackdown
financefeeds.com - April 11 at 1:45 PM
SEC Warns DeFi Firm Uniswap Labs of Potential LawsuitSEC Warns DeFi Firm Uniswap Labs of Potential Lawsuit
wsj.com - April 10 at 6:02 PM
Affinius Capital warns new SEC rules will have significant effect on operationsAffinius Capital warns new SEC rules will have 'significant effect' on operations
bizjournals.com - April 9 at 8:48 PM
FINRA Fines Florida B/D $500K For Not Retaining Business-Related TextsFINRA Fines Florida B/D $500K For Not Retaining Business-Related Texts
wealthmanagement.com - April 8 at 2:13 PM
SEC Charges Advisory Firm Senvest Management with Recordkeeping and Other FailuresSEC Charges Advisory Firm Senvest Management with Recordkeeping and Other Failures
tradersmagazine.com - April 5 at 4:56 AM
Global View Capital Advisors Selects OneVest as its Wealth Management Platform PartnerGlobal View Capital Advisors Selects OneVest as its Wealth Management Platform Partner
tmcnet.com - April 4 at 6:56 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Faircourt Gold Income

TSE:FGX
Faircourt Gold Income Corp. is a closed-ended equity mutual fund launched and managed by Faircourt Asset Management Inc. It invests in the public equity markets of Canada. The fund seeks to invest in stocks of companies operating in the precious metals sector, with an emphasis on companies involved in gold mining and exploration. It primarily invests in stocks of senior and intermediate gold producers that are part of the S&P/TSX Global Gold Index. The fund benchmarks the performance of its portfolio against S&P/TSX Global Gold Index. Faircourt Gold Income Corp. was formed on November 16, 2007 and is domiciled in Canada.
The Goldman Sachs Group logo

The Goldman Sachs Group

NYSE:GS
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Mirion Technologies logo

Mirion Technologies

NYSE:MIR
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Pharmerica logo

Pharmerica

NYSE:PMC
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.
Senvest Capital logo

Senvest Capital

TSE:SEC
Senvest Capital Inc., through its subsidiaries, holds investments in equity and real estate holdings in the United States and internationally. The company invests in derivative financial instruments comprising primarily options and warrants to purchase or sell equities, equity indices and currencies, equity swaps, foreign currency forward contracts, and foreign currency futures contracts. It also has investments as minority interests in private entities whose main assets are real estate properties; and real estate income trusts and partnerships. In addition, the company invests in self-storage facilities in Spain. The company was formerly known as Sensormatic Canada Limited and changed its name to Senvest Capital Inc. in April 1991. Senvest Capital Inc. was incorporated in 1968 and is headquartered in Montreal, Canada.